Press Releases

2020-04-27 // CALIXAR enters into collaboration with Kobe University to explore stabilized native membrane protein dynamics in reconstituted membranes using fluorescence

2020-03-10 // CALIXAR launches new funding round to establish business strategy

2020-02-13 // CALIXAR (Lyon, France) and the CBI/IGBMC (Strasbourg, France) announce a strategic Cryo Electron Microscopy (Cryo-EM) partnership

2019-11-06 // CALIXAR and COSMO BIO to conclude distribution agreement

2019-05-20 // Biotem enters into collaboration with Calixar for the development of therapeutic antibodies against membrane protein targets

2019-04-29 // Calixar signs exclusive licensing agreement with Regeneron on undisclosed therapeutic target

2019-04-05 // Calixar announces a collaborative research agreement with Thermo Fisher Scientific on multiple membrane proteins of high relevance to drug discovery

2017-11-28 // CALIXAR and ASTRAZENECA to publish new insight on KCC2 architecture and function in Scientific Reports

2016-06-24 // CALIXAR and University of Avignon to launch new research lab developing innovative chemistry for target discovery

2015-12-04 // CALIXAR and Biouniversa to publish unprecedented new insights on Pancreatic Ductal Adenocarcinoma (PDAC) in Nature Communications

2015-02-23 // CALIXAR raises €1 Million

2014-10-20 // CALIXAR and ASTON University collaboration on multidrug resistance targets

2014-09-23 // Major Breakthrough in Influenza Vaccines

2014-06-16 // New Strategic Compounds

2014-06-16 // CALIXAR to extend its portfolio of strategic compounds for complex pharmaceutical target isolation

2013-10-01 // ABL Strategic Marketing

2012-06-18 // CALIXAR closes an initial €875,000 funding round